Filing Details
- Accession Number:
- 0001127602-23-005808
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 16:02:24
- Reporting Period:
- 2023-02-15
- Accepted Time:
- 2023-02-17 16:02:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-02-15 | 19,892 | $250.00 | 216,702 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-02-15 | 108 | $250.16 | 216,594 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,328 | Indirect | 2021 GRAT |
Common Stock | 11,000 | Indirect | 2022 GRAT |
Common Stock | 13,640 | Indirect | 2020 GRAT |
Common Stock | 750 | Indirect | By Trust |
Common Stock | 340 | Indirect | By Trust |
Common Stock | 2,250 | Indirect | By Trust |
Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
- On 2/01/2023: 3,672 shares were transferred from the 2021 GRAT account to Direct Holdings.